“Allen & Gledhill LLP’s six-partner team delivers ‘prompt service that demonstrates very good industry knowledge’. The firm has a dedicated biotechnology practice, particularly focusing on advising pharmaceutical companies on various regulatory issues that arise over experimentation clinical trials and drug administration.” The Asia Pacific Legal 500 2009/2010
“‘There is a huge amount of skill at this firm,’ say sources, highlighting the ‘deep technical expertise and truly business-centred attitude’ of the lawyers. Clients say ‘the partners are incredibly responsive and open to feedback,’ and state they would not hesitate to take IP work to the firm, whether regarding patents, designs, trade marks or trade dress.” Chambers Asia 2009
The Intellectual Property & Technology (IP&T) group advises on a broad range of intellectual property matters in relation to fields as diverse as biotechnology,
healthcare, pharmaceuticals, computers, software, media and entertainment.
We undertake the full range of enforcement, management and transactional
matters.
Our enforcement work includes advising, prosecuting and defending
our clients’ IP rights, including making urgent court applications
for injunctions and search and seizure orders. We also plan, manage
and coordinate regional anti-counterfeiting programmes and also
have specialists to undertake information technology (IT) disputes,
such as those relating to software projects, technology-licensing
and domain names.
Our IP protection & management work encompasses patents, designs,
trade marks and trade dress. We advise on the clearance, protection
and exploitation of IP rights, as well as manage and co-ordinate
our clients’ IP portfolios in Singapore and worldwide. We also undertake
IP audits and due diligence exercises.
Our transactional team handles technology and communications matters,
including drafting and reviewing contracts, assisting in negotiations,
and advising on regulatory compliance. The areas we cover include
IT, Internet and e-commerce, telecommunications, research
and development, biotechnology, franchising, technology transfer
and IP licensing.
For further information, please contact:
Stanley Lai
Find out more about …
|